Free digital tool could speed up chronic pain care in underserved areas

NCT ID NCT07696676

Not yet recruiting Diagnosis Sponsor: Universidad Central de Venezuela Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study tests a free, mobile-friendly digital tool designed to help healthcare providers quickly determine the right level of care for people with chronic pain. The tool uses five standard questionnaires to generate a recommendation—from primary care to specialist referral. Researchers will compare the tool's suggestions with decisions made by a panel of pain specialists to see how accurate it is. The goal is to provide a low-cost way to improve pain management in places with limited resources.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PREDICT-DOLOR VE (rule-based clinical decision support tool)
What this could lead to: If accurate, this free digital tool could help doctors in low-resource areas quickly and consistently match chronic pain patients to the right specialist or care level, reducing delays and improving outcomes.
What could go wrong: This is a relatively small study (120 participants) testing diagnostic accuracy, not treatment effectiveness. The tool may not perform as well in other settings or populations, and it relies on patient-reported data.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Chronic Pain chronic pain syndrome neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PAIN NEUROPATHIC PAIN PAIN MANAGEMENT

More trials for these conditions

Other studies related to the condition(s) this trial covers.